ClinicalTrials.Veeva
Menu

Find clinical trials for Glioblastoma (GBM) in Barcelona, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Recurrence
Brain Cancer
Glioma
Cancer
Astrocytoma
Gliosarcoma

Glioblastoma (GBM) trials near Barcelona, CT, ESP:

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations (FIGHT-209)

This is an open-label, monotherapy study of pemigatinib in participants with recurrent glioblastoma (GBM) or other recurrent glioma...

Active, not recruiting
Glioblastoma
Adult-type Diffuse Gliomas
Drug: Pemigatinib

Phase 2

Incyte
Incyte

Barcelona, Spain and 80 other locations

as a monotherapy in participants with newly diagnosed or recurrent epidermal growth factor receptor variant III (EGFRvIII)-positive glioblastoma...

Active, not recruiting
Glioblastoma
Drug: RO7428731

Phase 1

Roche
Roche

Barcelona, Spain and 10 other locations

and tolerability of these combinations in adult participants with glioblastoma (GBM).The primary purpose of Phase 2 of this study is...

Enrolling
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Astrocytoma, Grade III
Radiation: Radiotherapy
Drug: Debio 0123

Phase 1, Phase 2

Debiopharm
Debiopharm

Barcelona, Spain and 9 other locations

The purpose of this first-in-human (FIH) study of \[177Lu\]-NeoB is to characterize the safety, tolerability, pharmacokinetics (PK) as well as the di...

Enrolling
Neoplasms
Drug: LCZ696
Drug: [177Lu]-NeoB

Phase 1, Phase 2

Advanced Accelerator Applications

Barcelona, Spain and 13 other locations

A Dose Finding Study of \[177Lu\]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination with Standard of Care and in Recurrent Glioblastoma...

Enrolling
Glioblastoma
Drug: [177Lu]Lu-DOTA-TATE
Other: Radiotherapy

Phase 1

Novartis
Novartis

Barcelona, Catalunya, Spain and 12 other locations

(TNBC), ovarian cancer, gastric cancer, colorectal cancer (CRC), glioblastoma (GBM), biliary tract cancers (BTC), or pancreatic can...

Active, not recruiting
Glioblastoma
Gastric Cancer
Biological: Pembrolizumab
Drug: Lenvatinib

Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Barcelona, Spain and 87 other locations

The purpose of the study is to test the safety and dosing of \[177Lu\]Lu-FF58, a radioligand therapy for patients with advanced or metastatic tumors...

Enrolling
Glioblastoma Multiforme
Gastroesophageal Adenocarcinoma
Drug: 177Lu-FF58
Drug: 68Ga-FF58

Phase 1

Novartis
Novartis

Hospitalet de LLobregat, Catalunya, Spain and 6 other locations

used as adjuvant treatment in patients with newly diagnosed GBM who are MGMT unmethylated and have completed concomitant treatment with temo...

Active, not recruiting
Glioblastoma Multiforme
Drug: Tinostamustine

Early Phase 1

Mundipharma
Mundipharma

Barcelona, Spain and 4 other locations

progression-free survival (PFS) of patients with newly diagnosed glioblastoma multiforme (GBM) can be improved by the addition of i...

Active, not recruiting
Glioblastoma
Procedure: Standard surgery
Drug: Temozolomide

Phase 3

Universitätsmedizin Mannheim

Barcelona, Spain and 18 other locations

when combined with standard of care treatment, temozolomide (TMZ) with or without radiotherapy (RT) in the newly diagnosed WHO Grade IV glioblastoma...

Active, not recruiting
Glioblastoma
Drug: Temozolomide
Radiation: Radiotherapy

Phase 1

Celgene
Celgene

Barcelona, Spain and 28 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems